| Date Filed | Type | Description |
| 03/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/01/2017 |
4
| PAPPAS ARTHUR M (10% Owner) has filed a Form 4 on CoLucid Pharmaceuticals, Inc. |
| 03/01/2017 |
4
| White Marvin L (Director) has filed a Form 4 on CoLucid Pharmaceuticals, Inc. |
| 03/01/2017 |
4
| Skwierczynski Raymond (Head,Pharmaceutical Operations) has filed a Form 4 on CoLucid Pharmaceuticals, Inc. |
| 03/01/2017 |
4
| Mathers Thomas P. (CEO) has filed a Form 4 on CoLucid Pharmaceuticals, Inc. |
| 03/01/2017 |
4
| Marengere Luc (10% Owner) has filed a Form 4 on CoLucid Pharmaceuticals, Inc. |
| 03/01/2017 |
4
| Lawton Alison Frances (Director) has filed a Form 4 on CoLucid Pharmaceuticals, Inc. |
| 03/01/2017 |
4
| Kuca Bernice (Head,Clin. and Reg. Operations) has filed a Form 4 on CoLucid Pharmaceuticals, Inc.|
Txns:
| Unknown transaction of 2,729 shares
@ $46.5, valued at
$126.9k
Disposed/sold 37,500 shares
@ $46.5, valued at
$1.7M
Disposed/sold 270,381 options to buy
@ $10, valued at
$2.7M
Disposed/sold 37,500 options to buy
@ $6.75, valued at
$253.1k
|
|
| 03/01/2017 |
4
| Hogan Linda C. (Head, Bus. Dev. and Strategy) has filed a Form 4 on CoLucid Pharmaceuticals, Inc. |
| 03/01/2017 |
4
| Dallas Matthew D (CFO) has filed a Form 4 on CoLucid Pharmaceuticals, Inc. |
| 03/01/2017 |
4
| CORRIGAN MARK (Director) has filed a Form 4 on CoLucid Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 8,114 options to buy
@ $3.79, valued at
$30.8k
Disposed/sold 8,897 options to buy
@ $6.24, valued at
$55.5k
|
|
| 01/27/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 01/05/2017 |
4
| Mathers Thomas P. (CEO) has filed a Form 4 on CoLucid Pharmaceuticals, Inc. |
| 01/05/2017 |
4
| Hogan Linda C. (Head, Bus. Dev. and Strategy) has filed a Form 4 on CoLucid Pharmaceuticals, Inc. |
| 01/04/2017 |
4
| Kuca Bernice (Head,Clin. and Reg. Operations) has filed a Form 4 on CoLucid Pharmaceuticals, Inc. |
| 01/04/2017 |
4
| Dallas Matthew D (CFO) has filed a Form 4 on CoLucid Pharmaceuticals, Inc. |
| 01/04/2017 |
4
| White Marvin L (Director) has filed a Form 4 on CoLucid Pharmaceuticals, Inc. |
| 01/04/2017 |
4
| Marengere Luc (10% Owner) has filed a Form 4 on CoLucid Pharmaceuticals, Inc. |
| 01/04/2017 |
4
| Lawton Alison Frances (Director) has filed a Form 4 on CoLucid Pharmaceuticals, Inc.|
Txns:
| Granted 658 options to buy
@ $36.2, valued at
$23.8k
|
|
| 12/05/2016 |
4
| Mathers Thomas P. (CEO) has filed a Form 4 on CoLucid Pharmaceuticals, Inc. |
| 12/05/2016 |
4
| Hogan Linda C. (Head, Bus. Dev. and Strategy) has filed a Form 4 on CoLucid Pharmaceuticals, Inc. |
| 12/01/2016 |
4
| Kuca Bernice (Head,Clin. and Reg. Operations) has filed a Form 4 on CoLucid Pharmaceuticals, Inc. |
| 12/01/2016 |
4
| Dallas Matthew D (CFO) has filed a Form 4 on CoLucid Pharmaceuticals, Inc. |
| 11/07/2016 |
4
| Mathers Thomas P. (CEO) has filed a Form 4 on CoLucid Pharmaceuticals, Inc. |
| 11/07/2016 |
4
| Hogan Linda C. (Head, Bus. Dev. and Strategy) has filed a Form 4 on CoLucid Pharmaceuticals, Inc. |
| 11/01/2016 |
4
| Hogan Linda C. (Head, Bus. Dev. and Strategy) has filed a Form 4 on CoLucid Pharmaceuticals, Inc. |
| 10/05/2016 |
4
| Mathers Thomas P. (CEO) has filed a Form 4 on CoLucid Pharmaceuticals, Inc. |
| 10/05/2016 |
4
| Hogan Linda C. (Head, Bus. Dev. and Strategy) has filed a Form 4 on CoLucid Pharmaceuticals, Inc. |
| 09/16/2016 |
4
| Mathers Thomas P. (CEO) has filed a Form 4 on CoLucid Pharmaceuticals, Inc. |
| 09/13/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/07/2016 |
4
| Hogan Linda C. (Head, Bus. Dev. and Strategy) has filed a Form 4 on CoLucid Pharmaceuticals, Inc. |
| 09/07/2016 |
4
| Mathers Thomas P. (CEO) has filed a Form 4 on CoLucid Pharmaceuticals, Inc. |
| 08/31/2016 |
4
| Skwierczynski Raymond (Head,Pharmaceutical Operations) has filed a Form 4 on CoLucid Pharmaceuticals, Inc. |
| 08/19/2016 |
4
| Skwierczynski Raymond (Head,Pharmaceutical Operations) has filed a Form 4 on CoLucid Pharmaceuticals, Inc. |
|